<SEC-DOCUMENT>0001193125-24-020146-index.html : 20240131
<SEC-HEADER>0001193125-24-020146.hdr.sgml : 20240131
<ACCEPTANCE-DATETIME>20240131062358
ACCESSION NUMBER:		0001193125-24-020146
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240131
GROUP MEMBERS:		FREDERICK V. FORTMILLER, JR.
GROUP MEMBERS:		HARRADEN CIRCLE INVESTORS GP, LLC
GROUP MEMBERS:		HARRADEN CIRCLE INVESTORS GP, LP
GROUP MEMBERS:		HARRADEN CIRCLE INVESTORS, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALPHATIME ACQUISITION CORP
		CENTRAL INDEX KEY:			0001889106
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93852
		FILM NUMBER:		24580550

	BUSINESS ADDRESS:	
		STREET 1:		500 5TH AVENUE, SUITE 938
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10110
		BUSINESS PHONE:		(347) 627-0058

	MAIL ADDRESS:	
		STREET 1:		500 5TH AVENUE, SUITE 938
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10110

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Harraden Circle Investments, LLC
		CENTRAL INDEX KEY:			0001910592
		ORGANIZATION NAME:           	
		IRS NUMBER:				813057945
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		299 PARK AVE
		STREET 2:		21ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10171
		BUSINESS PHONE:		212 832 4111

	MAIL ADDRESS:	
		STREET 1:		299 PARK AVE
		STREET 2:		21ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10171
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>d886494dsc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: d886494dsc13ga.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d886494dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: d886494dex991.htm

</DOCUMENT>
</SEC-DOCUMENT>